CNBC May 22, 2018
Christina Farr

  • 23andMe took the controversial approach of going directly to consumers with its health test.
  • The typical model requires a doctor’s prescription before administering tests.
  • CEO Anne Wojcicki was committed to the idea that people should have easy access to their own health data.

For more than a decade, Anne Wojcicki had a simple goal: Give people direct access to their medical data.

Consumers have been able to digitally track and control their finances, travel and shopping since the early days of the internet. But retrieving their most sensitive health information, like whether they’re at risk of cancer or could be a carrier for sickle cell anemia, requires a prescription from a doctor.

So in 2006, Wojcicki...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Precision Medicine, Technology
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article